Oxford Immunotec Usa, Inc.
Doing business as Oxford Immunotec
- UEI
- XVW6MZUM8NH3
- CAGE
- 94ZE6
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Website
- oxfordimmunotec.com
- Founded
- 2001
- Employees
- 251-1K
- Estimated annual revenue
- $50M-$100M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| T spot TB reagents option year 1 | Veterans Integrated Service Network 2 | $46,641 |
About Oxford Immunotec Usa, Inc.
Oxford Immunotec USA, Inc., doing business as Oxford Immunotec and a subsidiary of Revvity Inc. Medical Imaging, LLC, is a leading global diagnostics company offering an FDA approved Tuberculosis test, T SPOT.TB, for detection and diagnosis of latent tuberculosis infection. The company has been registered in SAM.gov since August 2021 as a foreign-owned, for-profit corporate entity.
Oxford Immunotec USA, Inc. has primarily provided T SPOT TB reagents to the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2 (VHA VISN 2) through firm-fixed-price blanket purchase agreement call contracts. These contracts, with a total value exceeding $400,000, have supplied the diagnostic test kits for tuberculosis screening programs within the VA medical network covering the New England region. No set-aside designations were used for these awards, awarded as sole-source procurements given Oxford Immunotec's proprietary T SPOT TB test.
In October 2021, Oxford Immunotec USA, Inc. was awarded a 5-year blanket purchase agreement by VHA VISN 2 with a potential value of $1,128,588.50 to provide T SPOT TB reagents through September 2026. Three firm-fixed-price call contracts totaling over $400,000 have been issued to date against this BPA for the delivery of tuberculosis diagnostic test kits from the company's facility in Marlborough, Massachusetts. These awards enable Oxford Immunotec to continue supplying its FDA-approved T SPOT TB test as an essential component of the VHA's tuberculosis screening and prevention efforts in New England healthcare facilities.
Quick answers
What is Oxford Immunotec Usa, Inc.'s UEI?
Oxford Immunotec Usa, Inc.'s Unique Entity ID (UEI) in SAM.gov is XVW6MZUM8NH3.
What is Oxford Immunotec Usa, Inc.'s CAGE code?
Oxford Immunotec Usa, Inc.'s CAGE code is 94ZE6.
What is Oxford Immunotec Usa, Inc.'s primary NAICS code?
Oxford Immunotec Usa, Inc.'s primary NAICS code is 424210 (Drugs and Druggists' Sundries Merchant Wholesalers).
Is Oxford Immunotec Usa, Inc. registered in SAM.gov?
Oxford Immunotec Usa, Inc.'s SAM.gov registration expired on March 19, 2024.
What is Oxford Immunotec Usa, Inc.'s most recent federal award?
Oxford Immunotec Usa, Inc.'s most recent federal contract award is T spot TB reagents option year 1 (36C24223N0099), from Veterans Integrated Service Network 2, on October 1, 2022.
On GovTribe
See Oxford Immunotec Usa, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors